On November 18, 2024, David Ramsay, Director at Savara Inc (SVRA, Financial), purchased 100,000 shares of the company, as reported in a recent SEC Filing. Following this transaction, the insider now owns a total of 2,323,642 shares of Savara Inc.
Savara Inc is a pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of rare respiratory diseases.
The shares were bought at a price of $2.88 per share, valuing the transaction at $288,000. This acquisition has increased the insider's stake in the company significantly.
The market cap of Savara Inc currently stands at approximately $507.99 million. The company's stock valuation metrics, such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, are also tracked for investor reference.
Over the past year, the insider transaction history for Savara Inc shows a trend with 1 insider buy and 3 insider sells. The recent purchase by David Ramsay aligns with the data indicating a potential positive shift in insider confidence regarding the company's future prospects.
For more detailed valuation metrics, investors might consider looking at the GF Value of Savara Inc to assess whether the stock is currently undervalued or overvalued.
This insider buying activity is often a key indicator watched by investors for insights into how corporate executives view the financial state and potential of the company they manage.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
